000 01341 a2200373 4500
005 20250515072942.0
264 0 _c20071107
008 200711s 0 0 eng d
022 _a0923-7534
024 7 _a10.1093/annonc/mdm221
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrimaldi, A M
245 0 0 _aSunitinib: bridging present and future cancer treatment.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cJun 2007
300 _avi31-4 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aForecasting
650 0 4 _aHumans
650 0 4 _aIndoles
_xtherapeutic use
650 0 4 _aProto-Oncogene Mas
650 0 4 _aPyrroles
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
_xtrends
650 0 4 _aSunitinib
700 1 _aGuida, T
700 1 _aD'Attino, R
700 1 _aPerrotta, E
700 1 _aOtero, M
700 1 _aMasala, A
700 1 _aCartenì, G
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 18 Suppl 6
_gp. vi31-4
856 4 0 _uhttps://doi.org/10.1093/annonc/mdm221
_zAvailable from publisher's website
999 _c17128787
_d17128787